Lonza collaborates with two innovation clusters

Lonza collaborates with two innovation clusters

11:32 AM, 11th December 2014
Lonza collaborates with two innovation clusters

BASEL, SWITZERLAND: Lonza recently entered into collaboration agreements with two prominent innovation clusters in France and Italy to help support small biotechnology companies that are developing novel therapeutics.

Medicen Paris Region is one of Europe’s biggest life sciences and healthcare clusters. Its goal is to highlight and reinforce the Paris Region as Europe’s leading industrial center for medical devices innovations and health technologies. BioPmed Innovation Cluster in Italy promotes and develops the use of different technological solutions from many companies to address unmet medical needs.

Clusters connect and collaborate with other clusters, bringing together large and small firms, research labs and educational establishments across Europe and the United States to develop synergies and work cooperatively. Lonza will offer cluster members technical presentations and workshops on specific Lonza technologies and will share its expertise and experience in a range of early-stage product development topics.

“These collaboration agreements will benefit Lonza by giving us a better understanding of the mid- and long-term strategies of the biotech industry in Europe. We will also get an early look at potential technology in-licensing opportunities and learn about new therapeutic and technological developments to benefit patients,” said Anne Hays, Head of Custom Development Services Organization, Lonza.


© Worldofchemicals News



Your Comments (Up to 2000 characters)
Please respect our community and the integrity of its participants. WOC reserves the right to moderate and approve your comment.

Related News

BASF builds chemical catalysts facility in Shanghai, China

ISELIN, US: BASF is further strengthening its manufacturing footprint in Asia Pacific with a new, world-scale chemical catalysts production facility a ...

Read more
Scientists create ‘artificial chemical evolution’

GLASGOW, SCOTLAND: Scientists have taken an important step towards the possibility of creating synthetic life with the development of a form of artifi ...

Read more
Evonik starts up crosslinking activator plants in Wesseling, Germany

ESSEN, GERMANY: Evonik has started up two new plant units for the production of crosslinking activators at its multi-user site in Wesseling, Germany. ...

Read more
BASF to invest €50 million in new innovation campus in Mumbai, India

MUMBAI, INDIA/LUDWIGSHAFEN, GERMANY: BASF broke ground on a new Innovation Campus in Navi Mumbai, India. The company will invest approximately €5 ...

Read more
Solvay acquires Brazilian specialty esters manufacturer, Dhaymers

SAO PAULO, BRAZIL: Solvay is acquiring Dhaymers, a Brazilian manufacturer of specialty esters, entering the skin care market and expanding its presenc ...

Read more
Reliance, Pemex JV for potential upstream oil and gas business opportunities in Mexico

MUMBAI, INDIA: Reliance Industries Limited (RIL) and the Mexican state owned company, Petroleos Mexicanos (Pemex) have entered into a Memorandum of Un ...

Read more
www.worldofchemicals.com uses cookies to ensure that we give you the best experience on our website. By using this site, you agree to our Privacy Policy and our Terms of Use. X